创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

CAI Dongcheng, LIU Hongxia, LIU Danmei, HAO Haiping, HE Chaoyong. Advances in the Research on Lipid Metabolism and Lipid-lowering Drugs[J]. Progress in Pharmaceutical Sciences, 2020, 44(5): 379-386.
Citation: CAI Dongcheng, LIU Hongxia, LIU Danmei, HAO Haiping, HE Chaoyong. Advances in the Research on Lipid Metabolism and Lipid-lowering Drugs[J]. Progress in Pharmaceutical Sciences, 2020, 44(5): 379-386.

Advances in the Research on Lipid Metabolism and Lipid-lowering Drugs

  • Atherosclerotic cardiovascular disease remains to be one of the diseases with the highest rates of morbidity and mortality worldwide. Dysfunctional lipid metabolism is a significant independent risk factor for atherosclerotic cardiovascular disease. In recent years, many innovative lipid-lowering drugs have appeared, and new advances have been made in the basic research on lipid metabolism. This article reviews the latest research progress of lipid-lowering drugs and related drug targets with an aim at providing new reference for the treatment of atherosclerotic cardiovascular disease.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return